Editor LSA

Sizzling Stock Alert: Cree, Inc. (NASDAQ:CREE), Expeditors International of Washington (NASDAQ:EXPD), Seattle Genetics, Inc. (NASDAQ:SGEN), Avago Technologies Ltd (NASDAQ:AVGO)

 

Lewes, DE -- (SBWIRE) -- 11/01/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Cree, Inc. (NASDAQ:CREE), Expeditors International of Washington (NASDAQ:EXPD), Seattle Genetics, Inc. (NASDAQ:SGEN), Avago Technologies Ltd (NASDAQ:AVGO)

Cree, Inc. (NASDAQ:CREE) opened its shares at the price of $61.13 for the day. Its closing price was $60.74 after losing -0.69% for the day. The company traded with the total volume of 1.76 million shares, while its average trading volume remained 3.13 million shares. The beta of CREE stands at1.16. Cree, Inc. develops, manufactures, and sells lighting-class light emitting diode (LED), lighting, and semiconductor products for power and radio-frequency (RF) applications in the United States, China, Europe, South Korea, Japan, Malaysia, and Taiwan.

Has CREE Found The Bottom and Ready To Move Up? Find Out Here

Expeditors International of Washington (NASDAQ:EXPD) percentage change plunged -2.26% to close at $45.29 with the total traded volume of 1.76 million shares, and average volume of 1.16 million. The 52 week range of the stock remained $34.83 - $46.90, while its day lowest price was $45.01 and it hit its day highest price at $46.48. Expeditors International of Washington, Inc. provides logistics services in the United States and internationally.

Has EXPD Found The Bottom And Ready To Gain Momentum? Find Out Here

Seattle Genetics, Inc. (NASDAQ:SGEN) started its trading session with the price of $39.93 and closed at $38.65 by scoring -3.16%. SGEN’s stocks traded with total volume of 1.75 million shares, while the average trading volume remained 856,393.00 shares. The beta of SGEN stands at 1.12. Day range of the stock was $38.58 -$40.27. Seattle Genetics, Inc., a biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for cancer.

Why Should Investors Buy SGEN After the Recent Fall? Just Go Here and Find Out

Avago Technologies Ltd (NASDAQ:AVGO) ended its day with the gain of +1.29% and closed at the price of $45.43 after opening at $45.00. Stock traded during its last trading session with the total volume of 1.74 million shares, as compared to its average volume of 2.78 million shares. Avago Technologies Limited engages in the design, development, and supply of analog semiconductor devices with a focus on III-V based products.

Will AVGO Continue To Move Higher? Find Out Here

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/